What are the Top 10 New Penny Stocks for 2022?

What are the Top 10 New Penny Stocks for 2022?

Penny stocks can be a great investment opportunity for investors looking for high-risk, high-reward investments. These stocks are typically priced below $5 per share and are known for their volatility and potential forquick gains. In this article, we will discuss the top 10 new penny stocks for 2022 that investors should consider.

1. Onconova Therapeutics Inc. (ONTX)

Onconova Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on discovering and developing small molecule drug candidates to treat cancer. The company's lead product candidate, rigosertib, has shown promise in treating a variety of hematologic malignancies.

2. Zomedica Corp. (ZOM)

Zomedica Corp. is a veterinary diagnostic and pharmaceutical company that focuses on developing products for companion animals. The company's flagship product, Truforma, is a diagnostic platform that provides veterinarians with quick and accurate results.

3. Acasti Pharma Inc. (ACST)

Acasti Pharma Inc. is a biopharmaceutical company that focuses on developing and commercializing prescription drugs for cardiovascular diseases. The company's lead product candidate, CaPre, is a omega-3 phospholipid concentrate that has shown promise in treating hypertriglyceridemia.

4. Greenlane Holdings Inc. (GNLN)

Greenlane Holdings Inc. is a global distributor of premium vaporization products and consumption accessories. The company operates in both the wholesale and direct-to-consumer markets and has a wide range of products, including vaporizers, e-cigarettes, and smoking accessories.

5. Immuron Limited (IMRN)

Immuron Limited is a clinical-stage biopharmaceutical company that focuses on developing and commercializing oral immunotherapeutics for the treatment of gut-mediated diseases. The company's lead product candidate, IMM-124E, is a oral immunotherapeutic that has shown promise in treating nonalcoholic steatohepatitis.

6. Applied DNA Sciences Inc. (APDN)

Applied DNA Sciences Inc. is a biotechnology company that focuses on using DNA-based technology to protect products, brands, and intellectual property. The company's products include DNA markers and authentication technologies that can be used to identify counterfeit products.

7. Jaguar Health Inc. (JAGX)

Jaguar Health Inc. is a commercial-stage pharmaceuticals company that focuses on developing and commercializing natural, plant-based products for human and animal health. The company's lead product, Mytesi, is an FDA-approved drug for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS.

8. Oncternal Therapeutics Inc. (ONCT)

Oncternal Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing novel oncology therapies. The company's lead product candidate, cirmtuzumab, is a potential treatment for a variety of cancers including chronic lymphocytic leukemia and breast cancer.

9. Pieris Pharmaceuticals Inc. (PIRS)

Pieris Pharmaceuticals Inc. is a clinical-stage biotechnology company that focuses on developing novel therapeutics for cancer, respiratory diseases, and other indications. The company's lead product candidate, PRS-343, is a bispecific antibody that has shown promise in treating HER2-positive solid tumors.

10. United States Antimony Corporation (UAMY)

United States Antimony Corporation is a mining and production company that focuses on antimony, silver, gold, and zeolite. The company's operations are primarily located in North America and China, and it has a strong track record of profitability and growth.

Investing in penny stocks can be risky, but with careful research and analysis, investors can identify promising companies that have the potential for significant growth. Before investing in any penny stock, it is important to do your due diligence and consult with a financial advisor to determine if it is a suitable investment for your portfolio.